Related references
Note: Only part of the references are listed.Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
Lieselotte Van Bockstal et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2020)
Interferon Alpha Favors Macrophage Infection by Visceral Leishmania Species Through Upregulation of Sialoadhesin Expression
Lieselotte Van Bockstal et al.
FRONTIERS IN IMMUNOLOGY (2020)
Neutrophil properties in healthy and Leishmania infantum-naturally infected dogs
Amanda Brito Wardini et al.
SCIENTIFIC REPORTS (2019)
Miltefosine enhances the fitness of a non-virulent drug-resistant Leishmania infantum strain
Eline Eberhardt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis
Lieselotte Van Bockstal et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2019)
Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine
Emily G. Armitage et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Histopathological and immunohistochemical characterisation of hepatic granulomas in Leishmania donovani-infected BALB/c mice: a time-course study
Francisco J. Salguero et al.
PARASITES & VECTORS (2018)
Neutrophils enhance early Trypanosoma brucei infection onset
Guy Caljon et al.
SCIENTIFIC REPORTS (2018)
A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis
Juliana B. T. Carnielli et al.
EBIOMEDICINE (2018)
NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway
Jaime Zamora-Chimal et al.
IMMUNOBIOLOGY (2017)
Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
Saumya Srivastava et al.
PARASITES & VECTORS (2017)
Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum
S. Hendrickx et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes
Annelies Mondelaers et al.
PLOS ONE (2016)
Stability of Reference Genes for Messenger RNA Quantification by Real-Time PCR in Mouse Dextran Sodium Sulfate Experimental Colitis
Nour Eissa et al.
PLOS ONE (2016)
Permissive and protective roles for neutrophils in leishmaniasis
E. D. Carlsen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Suppression of Fcγ-Receptor-Mediated Antibody Effector Function during Persistent Viral Infection
Douglas H. Yamada et al.
IMMUNITY (2015)
Inflammasomes Coordinate Pyroptosis and Natural Killer Cell Cytotoxicity to Clear Infection by a Ubiquitous Environmental Bacterium
Vivien I. Maltez et al.
IMMUNITY (2015)
Lack of correlation between the promastigote back-transformation assay and miltefosine treatment outcome
S. Hendrickx et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Seth B. Coffelt et al.
NATURE (2015)
NK-, NKT- and CD8-Derived IFNγ Drives Myeloid Cell Activation and Erythrophagocytosis, Resulting in Trypanosomosis-Associated Acute Anemia
Jennifer Cnops et al.
PLOS PATHOGENS (2015)
Donor CD4 T Cells Trigger Costimulation Blockade-Resistant Donor Bone Marrow Rejection Through Bystander Activation Requiring IL-6
K. Hock et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Miltefosine Increases Lipid and Protein Dynamics in Leishmania amazonensis Membranes at Concentrations Similar to Those Needed for Cytotoxicity Activity
Rodrigo Alves Moreira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L-infantum
S. Hendrickx et al.
PARASITOLOGY RESEARCH (2014)
Epidemiology of visceral leishmaniasis
Paul D. Ready
CLINICAL EPIDEMIOLOGY (2014)
Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance
Suman Rijal et al.
CLINICAL INFECTIOUS DISEASES (2013)
Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B-miltefosine-loaded nanocochleates
T. T. H. Pham et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Identification of phospholipid species affected by miltefosine action in Leishmania donovani cultures using LC-ELSD, LC-ESI/MS, and multivariate data analysis
L. Imbert et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Neutrophilic Granulocytes Modulate Invariant NKT Cell Function in Mice and Humans
Gerhard Wingender et al.
JOURNAL OF IMMUNOLOGY (2012)
Invariant NKT Cells Drive Hepatic Cytokinic Microenvironment Favoring Efficient Granuloma Formation and Early Control of Leishmania donovani Infection
Florence Robert-Gangneux et al.
PLOS ONE (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival
Norikiyo Ueno et al.
TRENDS IN PARASITOLOGY (2012)
Efficient Capture of Infected Neutrophils by Dendritic Cells in the Skin Inhibits the Early Anti-Leishmania Response
Flavia L. Ribeiro-Gomes et al.
PLOS PATHOGENS (2012)
Leishmania Resistance to Miltefosine Associated with Genetic Marker
Sandrine Cojean et al.
EMERGING INFECTIOUS DISEASES (2012)
Leishmania donovani glycosphingolipid facilitates antigen presentation by inducing relocation of CD1d into lipid rafts in infected macrophages
Subir Karmakar et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Leukocytes Infiltrate the Skin and Draining Lymph Nodes in Response to the Protozoan Leishmania infantum chagasi
Colin J. Thalhofer et al.
INFECTION AND IMMUNITY (2011)
Leishmaniasis: complexity at the host-pathogen interface
Paul Kaye et al.
NATURE REVIEWS MICROBIOLOGY (2011)
Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes
Fernanda de Aquino Marinho et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2011)
IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo
Simone Haeberlein et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
The Prominent Role of Neutrophils during the Initial Phase of Infection by Leishmania Parasites
Melanie Charmoy et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Disruption of the Lipid-Transporting LdMT-LdRos3 Complex in Leishmania donovani Affects Membrane Lipid Asymmetry but Not Host Cell Invasion
Adrien Weingaertner et al.
PLOS ONE (2010)
Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes
A. Saint-Pierre-Chazalet et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Cytokine-secreting follicular T cells shape the antibody repertoire
R. Lee Reinhardt et al.
NATURE IMMUNOLOGY (2009)
Leishmania major:: Recruitment of Gr-1+ cells into draining lymph nodes during infection is important for early IL-12 and IFNγ production
Milla Schmaltz Tatico dos Santos et al.
EXPERIMENTAL PARASITOLOGY (2008)
Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani
Emma McFarlane et al.
INFECTION AND IMMUNITY (2008)
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs
Ulrike Schleicher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes
Juan Roman Luque-Ortega et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Balancing immunity and pathology in visceral leishmaniasis
Amanda C. Stanley et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Oral miltefosine for the treatment of Indian visceral leishmaniasis
Shyam Sundar et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Immature human dendritic cells infected with Leishmania infantum are resistant to NK-mediated cytolysis but are efficiently recognized by NKT cells
Yolanda Campos-Martin et al.
JOURNAL OF IMMUNOLOGY (2006)
Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions
M Rakotomanga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Hexadecylphosphocholine interaction with lipid monolayers
M Rakotomanga et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)
Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes
C Paris et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The immunopathology of experimental visceral leishmaniasis
PM Kaye et al.
IMMUNOLOGICAL REVIEWS (2004)
Possible mechanism of miltefosine-mediated death of Leishmania donovani
NK Verma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Distinct roles for lymphotoxin-α and tumor necrosis factor in the control of leishmania donovani infection
CR Engwerda et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis
CR Engwerda et al.
TRENDS IN PARASITOLOGY (2004)
A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan
JL Amprey et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2
I Becker et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2003)
Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug
FJ Pérez-Victoria et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Oral miltefosine for Indian visceral leishmaniasis
S Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment
HW Murray et al.
INFECTION AND IMMUNITY (2000)
Organ-specific immune responses associated with infectious disease
CR Engwerda et al.
IMMUNOLOGY TODAY (2000)
Share Paper
